Paradeep Phosphates Limited concluded its 44th Annual General Meeting on September 17, 2026, successfully passing all eight proposed resolutions. Key approvals included the adoption of financial statements, dividend declaration, and the launch of the Performance Stock Option Plan 2026. While most items received near-unanimous support, the new ESOP plan faced notable pushback from approximately 18.84% of participating shareholders.
Paradeep Phosphates AGM: Shareholders Clear All Eight Proposals
All eight resolutions at the 44th Annual General Meeting were passed, including a new performance-based stock option plan.
Reader Takeaway: Management secured all approvals, though the new ESOP plan faced dissent from nearly 19% of voters.
What just happened
Paradeep Phosphates held its 44th Annual General Meeting (AGM) on September 17, 2026. Shareholders greenlit all items on the agenda, which included the adoption of standalone and consolidated financial statements for the fiscal year ending March 31, 2026, and the formal declaration of a dividend.
Key Resolutions
Aside from standard procedural approvals like the ratification of cost auditor remuneration and the re-appointment of Mr. Saroj Kumar Poddar as Chairman, the meeting focused on strategic governance. Shareholders approved:
- The ‘Paradeep Phosphates Limited Performance Stock Option Plan 2026’.
- Material Related Party Transactions.
- Remuneration packages for non-executive directors.
Voting Dynamics
Shareholder support was overwhelmingly positive for routine business, with over 99.9% of votes in favor of financial statements, dividends, and auditor appointments. However, the new ESOP plan saw the most significant scrutiny, with 18.84% of votes cast against it. Re-appointment and continuation of Chairman Saroj Kumar Poddar saw roughly 97.1% support.
What to track next
Investors should monitor future exchange filings for specific details regarding the implementation of the 2026 Performance Stock Option Plan. Additionally, look for subsequent disclosures related to the approved material related-party transactions to understand their impact on the company’s capital allocation.
